ACAD Chart
- 52-Week Range: $15.29 - $27.50
- Market Capitalization: $2.71B
- Short Percentage: 0%
- Target Price: $28.89
- Shares Outstanding: 161.43M
- Next Earnings: May 4
Catalysts
CategoryCatalyst
Earnings
ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
Earnings
ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Acadia Pharmaceuticals to Announce First Quarter 2022 Financial Results on May 4, 2022Business Wire | April 21st
- Alzamend Neuro Appoints Dr. Terri Hunter to Its Scientific Advisory BoardBusiness Wire | April 4th
- ACADIA Pharmaceuticals, Inc. (ACAD) CEO Stephen Davis on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 28th
- Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022Business Wire | February 14th
Company Info
Website: https://www.acadia-pharm.com
Address: 12830 El Camino Real, San Diego, CA, United States, 92130
Sector: Healthcare
Industry: Biotechnology
Full time employees: 514
Address: 12830 El Camino Real, San Diego, CA, United States, 92130
Sector: Healthcare
Industry: Biotechnology
Full time employees: 514
$ACAD Like if you’re a bull
$ACAD lfg!!! So much movement ! Buy n hodl!
$ACAD go to the bathroom
come back to green! I like it!
$ACAD going green
$ACAD tomorrow will be an explosion day
I believe it!
$ACAD buying all the dips.
$ACAD Tomorrow
$ACAD omg lol
$ACAD PT?
$ACAD what V recovery or fake pump